Financials

  • Market Capitalization 122.16 B
  • Employee 6 400
  • Founded 1989
  • CEO Reshma Kewalramani
  • Website www.vrtx.com
  • Headquarter Massachusetts, United States
  • FIGI BBG000C1S2X2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
29.59
Price to sales ratio
9.75

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
241
REGN
Regeneron Pharmaceuticals, Inc. - Common Stock
659.61 USD-0.74%+1.49%+8.33%+16.52%69.15 B USD
294
ARGX
argenx SE - American Depositary Shares
871.80 USD-0.66%-6.02%-3.13%+56.02%53.95 B USD
382
RVMD
Revolution Medicines, Inc. - Common Stock
181.70 USD-2.77%-4.07%+18.73%+227.98%38.63 B USD
386
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
286.24 USD-4.19%-9.06%-0.94%-9.11%38.22 B USD

Frequently asked questions about Vertex Pharmaceuticals Incorporated - Common Stock

What is the Vertex Pharmaceuticals Incorporated - Common Stock stock price today?

The current price of Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) is 481.31. Over the past 24 hours, the stock has changed by -0.84%. Follow the VRTX chart for real-time price dynamics.

What is the stock ticker of Vertex Pharmaceuticals Incorporated - Common Stock?

Vertex Pharmaceuticals Incorporated - Common Stock trades under the ticker VRTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Vertex Pharmaceuticals Incorporated - Common Stock stock going up?

VRTX has changed by -9.09% over the last week, +9.38% over the last month, and +3.06% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Vertex Pharmaceuticals Incorporated - Common Stock net income for the last quarter?

Vertex Pharmaceuticals Incorporated - Common Stock reported net income of 1.03 B for the last quarter. The previous quarter showed 1.19 B, which means net income changed by -13.41%.

How many employees does Vertex Pharmaceuticals Incorporated - Common Stock have?

As of the latest available data, Vertex Pharmaceuticals Incorporated - Common Stock has 6 400 employees. Workforce size can provide additional context about the company's scale and operations.

What is Vertex Pharmaceuticals Incorporated - Common Stock EBITDA?

Vertex Pharmaceuticals Incorporated - Common Stock EBITDA is 1.19 B, and its EBITDA margin is 39.97%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Vertex Pharmaceuticals Incorporated - Common Stock stock?

You can buy Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Vertex Pharmaceuticals Incorporated - Common Stock stock?

Investing in Vertex Pharmaceuticals Incorporated - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VRTX chart and related analysis on metatrader.com as part of your research.

Vertex Pharmaceuticals Incorporated - Common Stock

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

News